Why Increased Cellular Uptake Does Not Prove Complete Transcellular Peptide Passage

Increased cellular uptake does not prove complete transcellular peptide passage because uptake measures entry into or association with epithelial cells, whereas transcellular transport requires the peptide to cross the apical membrane, survive intracellular trafficking, avoid irreversible sequestration or degradation, reach the basolateral region, exit the cell, and ultimately appear on the opposite side of the epithelial barrier. Fluorescence microscopy, flow cytometry, and cellular peptide measurements can therefore support a cell-entry mechanism without establishing successful transepithelial passage.

This distinction is essential within permeation-enhancer research for peptide oral films. A formulation can produce striking intracellular fluorescence or increased cell-associated peptide while showing little complete transport across a tissue or epithelial model.

Research-use notice concerning cellular uptake and complete transcellular peptide passage: InStrips products are offered exclusively for research and analytical investigation of epithelial uptake, intracellular localization, transcytosis, peptide flux, and related oral-film transport mechanisms. Increased cellular peptide uptake should not be interpreted as evidence for diagnosis, treatment, cure, prevention, management of disease, correction of an absorption disorder, or any other medical or clinical outcome.

The safest way to interpret these studies is to divide transcellular transport into consecutive evidence levels. Entry is necessary for many transcellular mechanisms, but entry is only the beginning of the route.

Stage 1: The Peptide Reaches the Cell Surface

Before uptake occurs, peptide must leave the dosage form and reach the epithelial membrane.

This requires successful movement through:

• hydrated film
• saliva or experimental medium
• surface mucin

depending on the model.

Surface Association Is Not Cellular Uptake

Peptides can bind strongly to the outside of cells through:

• electrostatic interactions
• hydrophobic interactions
• binding to membrane proteins

without crossing the plasma membrane.

This Can Produce False Uptake Signals

A fluorescence assay that measures total cell-associated signal can contain contributions from:

• surface-bound peptide
• internalized peptide

unless these fractions are distinguished experimentally.

Surface Stripping Can Improve Uptake Measurements

Methods may include:

• extensive washing
• trypsin treatment
• acidic surface stripping
• membrane-impermeant quenchers

depending on peptide chemistry and cell type.

Cell-Penetrating Peptide Research Demonstrated This Problem Clearly

Early studies of highly cationic peptides reported extremely rapid cellular entry.

Later methodological work showed that:

• cell fixation
• surface-associated peptide

could create misleading uptake patterns.

Fixation Can Redistribute Membrane-Bound Peptide

Certain cationic peptides can move during conventional fixation procedures.

This may produce apparent intracellular localization that was not present in the same way in living cells.

Live-Cell Imaging Can Reduce This Artifact

Studying living cells avoids some redistribution produced by fixation.

Researchers can compare:

• live-cell microscopy
• fixed-cell microscopy

to determine whether the localization pattern changes.

Stage 2: The Peptide Crosses the Apical Membrane

Once true internalization is demonstrated, researchers can ask how entry occurred.

Possible mechanisms include:

• direct membrane translocation
• endocytosis
• another active uptake process

Endocytosis Places Peptide Inside a Vesicle

Endocytic uptake surrounds extracellular material with cellular membrane and creates an intracellular vesicle.

This can produce strong intracellular signal without releasing peptide into the cytosol.

Endosomal Uptake Is Not Complete Transcellular Passage

A peptide trapped inside an endosome has crossed the external cellular boundary in one sense but has not yet:

• crossed the entire epithelial cell
• reached the basolateral surface
• entered the receiver compartment

Intracellular Localization Should Be Resolved Spatially

Researchers can compare peptide signal with markers for:

• early endosomes
• late endosomes
• lysosomes
• other intracellular compartments

using microscopy.

Co-Localization Can Reveal Sequestration

If much of the peptide remains co-localized with endosomal or lysosomal markers, the experiment supports intracellular uptake but may also indicate restricted onward transport.

Lysosomal Delivery Can Lead to Peptide Degradation

Intracellular vesicles can progress toward enzyme-rich compartments.

For peptide molecules, this can lead to:

• proteolytic cleavage
• loss of intact peptide

Total Fluorescence May Survive Peptide Cleavage

If a fluorescent label remains attached to a peptide fragment, microscopy can continue to show signal even though the original peptide is no longer intact.

Fluorescence therefore does not automatically establish molecular integrity.

Chemical Analysis Can Distinguish Parent Peptide From Fragments

Researchers may use:

• liquid chromatography
• mass spectrometry
• validated peptide-specific assays

to determine whether the internalized and transported material remains chemically intact.

Stage 3: The Peptide Escapes Intracellular Sequestration

For some delivery systems, peptide needs to leave an endosomal compartment before it can access:

• cytosol
• another intracellular transport route

This step is often called endosomal escape.

Endosomal Escape Is Not Always Required for Transcytosis

A peptide can theoretically remain inside vesicular compartments while those vesicles move toward the opposite cellular surface.

This is a different process from cytosolic delivery.

Transcytosis Combines Endocytosis and Exocytosis

A simplified transcytotic sequence is:

• apical uptake
• intracellular vesicular trafficking
• movement toward the opposite membrane
• exocytosis

Successful uptake establishes only the first of these stages.

Cell-Penetrating and Transcytosing Peptides Should Be Distinguished

A peptide that efficiently enters individual cells may accumulate:

• in cytoplasm
• inside vesicles
• at intracellular membranes

without being efficiently exported on the opposite side.

Transcytosing Systems Are Selected for Productive Passage

A transcytosis strategy aims to combine:

• cell entry
• intracellular trafficking
• cell exit

rather than maximize uptake alone.

Stage 4: The Peptide Reaches the Basolateral Region

In a polarized epithelial cell, the apical and basolateral surfaces are biologically different.

Complete transcellular transport requires movement:

• from the exposure side
• toward the opposite cellular domain

Intracellular Distribution Can Be Polarized

A peptide may remain primarily near the apical region rather than moving deeper through the cell.

Confocal microscopy can help examine:

• vertical distribution
• depth within the cell layer

A Single Two-Dimensional Image Can Be Misleading

Conventional microscopy can project signal from different depths into one image.

Three-dimensional imaging or optical sectioning provides stronger localization evidence.

Stage 5: Basolateral Exit Must Occur

Even a peptide that reaches the opposite cellular membrane has not completed passage until it exits into:

• the basolateral extracellular environment

or, in a tissue experiment:

• deeper mucosal compartments

Exocytosis Is a Separate Biological Process

Export can depend on:

• vesicle trafficking
• membrane fusion
• sorting pathways

that are not measured by a standard uptake assay.

Stage 6: Peptide Appears in the Receiver Compartment

In a polarized epithelial model, the strongest evidence of complete transepithelial passage is measurement of intact peptide on the opposite side.

This can be quantified as:

• cumulative transport
• apparent permeability coefficient
• flux

Receiver Appearance Is Stronger Transport Evidence Than Intracellular Fluorescence

A peptide detected in the receiver compartment has completed more of the pathway than one detected only:

• on the cell surface
• inside the cell

Even Receiver Detection Needs Molecular Verification

The measured material could theoretically include:

• intact peptide
• peptide fragments
• free fluorescent label

depending on the analytical method.

Mass Spectrometry Can Strengthen Passage Evidence

Confirming molecular mass or sequence-associated features provides stronger evidence that:

• the parent peptide

rather than merely a label crossed the epithelial preparation.

Cellular Uptake Can Increase While Transepithelial Flux Remains Low

This can occur when peptide is:

• retained in membranes
• trapped in endosomes
• degraded intracellularly
• poorly exported

after entering the cell.

Membrane Partitioning Provides One Retention Mechanism

A peptide with strong lipid affinity may accumulate in cellular membranes.

This is why peptide partitioning into epithelial membranes needs to be evaluated separately from complete passage.

Endocytosis Can Produce Another Retention Mechanism

Efficient internalization into vesicles can create a large intracellular peptide pool without efficient transcytosis.

The uptake endpoint can therefore improve while net delivery remains limited.

Flow Cytometry Measures Cell-Associated Fluorescence

Flow cytometry can quantify fluorescence across thousands of cells.

It is useful for determining:

• fraction of positive cells
• relative signal intensity
• population variability

Flow Cytometry Needs Surface-Control Procedures

Classic cell-penetrating peptide research demonstrated that surface-bound cationic peptides can produce misleading flow-cytometry measurements unless extracellular material is adequately removed.

This is especially important for strongly membrane-binding peptides.

Microscopy Answers a Different Question

Microscopy can provide information about:

• location
• cellular compartment
• depth of penetration

but usually quantifies fewer cells than flow cytometry.

Combining the Methods Is More Informative

A stronger cellular-uptake experiment may combine:

• flow cytometry
• live-cell confocal microscopy
• chemical peptide analysis

rather than relying on one fluorescence endpoint.

Temperature Dependence Can Suggest Active Uptake

Researchers can compare internalization at:

• physiological temperature
• reduced temperature

because energy-dependent endocytosis is generally reduced at low temperature.

Temperature Experiments Are Not Mechanistically Perfect

Cooling also changes:

• membrane fluidity
• protein function
• other cellular processes

A temperature effect alone does not identify one specific endocytic pathway.

Pathway Inhibitors Can Add Evidence

Researchers may use inhibitors associated with:

• clathrin-mediated uptake
• caveolar processes
• macropinocytosis

and determine whether peptide uptake changes.

Inhibitor Specificity Is a Limitation

Many pharmacological uptake inhibitors affect more than one cellular process.

Conclusions should therefore be strengthened with:

• genetic perturbation
• multiple independent approaches

where feasible.

Polarized Epithelial Models Are More Informative Than Isolated Cells

A conventional cell line grown on plastic can demonstrate cellular uptake.

It cannot easily demonstrate directional transport from:

• apical side
• to basolateral side

Transwell Systems Add Directionality

Cells grown on permeable supports create separate:

• apical compartments
• basolateral compartments

allowing peptide passage to be measured directly.

Barrier Validation Is Essential in Transwell Research

If the cell layer contains gaps, peptide appearing basolaterally may have passed:

• between damaged cells

rather than through them.

Researchers therefore measure barrier integrity alongside transport.

TEER Can Help Validate the Epithelial Layer

Electrical resistance provides one measure of cell-layer integrity.

A sharp decline during an experiment can indicate:

• barrier perturbation

that complicates transcellular interpretation.

Paracellular Markers Provide Another Control

Hydrophilic marker molecules can be included to determine whether general between-cell permeability changes.

If peptide transport rises while a paracellular marker remains relatively stable, the result can support a more transcellular interpretation.

This Is Still Not Absolute Proof

Different molecules have different:

• sizes
• charges
• diffusion coefficients

so one marker cannot represent every paracellular pathway.

Stratified Oral Tissue Is More Complex Than a Monolayer

Buccal mucosa contains many cell layers.

A peptide can enter superficial cells successfully yet fail to reach:

• deeper epithelial layers
• connective tissue
• the receiver compartment

Depth-Resolved Tissue Imaging Can Address This

Researchers may section mucosa after exposure and examine peptide distribution by depth.

This can distinguish:

• surface association
• superficial-cell uptake
• deep epithelial penetration

Complete Mucosal Passage Is Stronger Than Deep Penetration

A peptide can reach deep epithelium and still remain retained in tissue.

Receiver-side recovery remains necessary to demonstrate complete passage across the preparation.

Tissue Accumulation Can Be Quantified Separately

A useful mass balance measures:

• donor peptide
• surface-associated peptide
• tissue peptide
• receiver peptide

after the same experiment.

This Reveals Whether Enhancement Changes Distribution or Passage

An enhancer might increase tissue peptide several-fold while producing only a small change in receiver flux.

That result suggests increased:

• entry or retention

rather than proportionally increased complete transport.

Cellular Uptake Can Also Be Chemically Nonproductive

A peptide may enter cells but undergo:

• proteolysis
• chemical modification

before exiting.

For delivery research, intact passage and total peptide-derived material are not equivalent.

Stable Isotope or Mass-Specific Analysis Can Help

Methods capable of identifying the parent molecule can distinguish:

• intact peptide
• metabolites
• degradation fragments

in donor, tissue, and receiver compartments.

Increased Uptake Can Still Be Mechanistically Valuable

A cellular-uptake result can establish that an enhancer or formulation changed:

• membrane access
• endocytosis
• intracellular accumulation

under the tested conditions.

The problem arises only when that endpoint is extended beyond what was measured.

Uptake Is One Step in an Evidence Ladder

A useful hierarchy is:

• surface association
• true cellular internalization
• intracellular localization
• movement toward the opposite cellular side
• basolateral release
• transepithelial flux
• complete mucosal passage

Each level provides stronger evidence of productive transcellular transport.

A Mechanistic Claim Should Match the Highest Demonstrated Level

If a study measures only intracellular fluorescence, an appropriate conclusion concerns:

• cellular uptake or localization

rather than complete epithelial transport.

Research Notes: Entry, Retention, and Passage Are Three Different Outcomes

Peptide-delivery studies become much easier to interpret when cellular uptake is divided into three questions. Did the peptide enter the cell? Did it remain there? Did it leave from the opposite side? A positive answer to the first does not determine the answers to the other two.

This is particularly important when evaluating permeation enhancers. Membrane fluidization or improved partitioning may produce impressive cellular uptake while simultaneously increasing membrane retention or endosomal sequestration. Complete transcellular transport therefore requires a directional transport experiment, not merely brighter cells.

External Cellular-Uptake Evidence

The PubMed-indexed study Cell-Penetrating Peptides: A Reevaluation of the Mechanism of Cellular Uptake demonstrated that fixation and extracellular membrane-associated peptide could create misleading uptake measurements for highly cationic cell-penetrating peptides. Live-cell microscopy instead revealed endosomal localization, illustrating why apparent cellular entry requires careful methodological validation before it is used to support a transport mechanism.

What Cellular-Uptake Research Can Establish

Depending on methodology, researchers may establish:

• cell-surface association
• true internalization
• endosomal localization
• cytosolic localization
• changes in uptake after an enhancer
• involvement of selected uptake pathways

What Increased Cellular Uptake Does Not Establish

Cellular uptake does not independently establish:

• basolateral peptide release
• complete transcellular passage
• complete passage across stratified oral mucosa
• intact peptide recovery on the opposite side
• human systemic exposure
• a clinical outcome

Questions to Ask Before Calling Uptake Transcellular Passage

Researchers should identify:

• Was surface-bound peptide removed?
• Were live cells examined?
• Was intracellular localization confirmed?
• Was intact peptide distinguished from fragments?
• Was a polarized epithelial model used?
• Was peptide measured on the basolateral side?
• Was barrier integrity maintained?
• Were paracellular markers measured?
• Was tissue retention quantified?
• Was complete mucosal passage measured directly?

Final Perspective

Increased cellular uptake does not prove complete transcellular peptide passage because entering an epithelial cell is only one stage of a much longer transport sequence.

A peptide can bind to the membrane, enter an endosome, accumulate inside the cell, become degraded, remain trapped in tissue, or fail to exit basolaterally despite showing strong cellular uptake.

The strongest transcellular evidence therefore combines validated internalization with intracellular localization, directional epithelial transport, intact peptide recovery, barrier controls, and tissue mass balance. Cellular uptake is mechanistically useful, but complete passage must be demonstrated on the opposite side of the epithelial barrier.